Neurocrine to buy Soleno Therapeutics for $2.9 billion.
Share this article
Corporate
Score 55
Neutral
Neurocrine to buy Soleno Therapeutics for $2.9 billion
Apr 06, 2026 11:12 UTC
NBIX, SLNO, ^GSPC
Short term
Related Articles
Score 25
Global X SuperDividend REIT ETF declares $0.152 dividend
Apr 06, 12:52
Score 35
Bullish
MicroCloud Hologram to invest $400M in Bitcoin protocol upgrade for quantum security
Apr 06, 12:50
Score 35
Bullish
Cirrus Logic in spotlight as KeyBanc ups price target
Apr 06, 12:50
Score 35
Bearish
Las Vegas Sands Shares Decline Following Jefferies' Earnings Outlook Adjustment
Apr 06, 12:49
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.